Key result
Within-hospital disparities in 30-day readmission for dual-eligible patients persisted after accounting for state- and community-level factors, with an adjusted rate difference of 0.87% for acute myocardial infarction, 0.67% for heart failure, and 0.42% for pneumonia.
Why the study?
The degree to which post-hospitalization disparities for dually eligible Medicare and Medicaid patients are driven by community-level factors versus hospital quality improvement remains debated.
Are there within-hospital disparities in 30-day readmission rates between dually eligible and non-dually eligible Medicare patients hospitalized for AMI, HF, or pneumonia?
Population
475 444 AMI, 898 395 HF, and 1 214 282 pneumonia patients aged ≥65 years
Comparison
Dually eligible (DE) vs non-DE patients
Design
Retrospective cohort study
Follow-up
30 days
Authors
Loading...
Disparities in 30-day readmissions for dual-eligible patients persist within hospitals; leaves open whether community factors or unmeasured differences drive them.
Cohort (n=2,588,121)
Yes
Are there within-hospital disparities in 30-day readmission rates between dually eligible and non-dually eligible Medicare patients hospitalized for AMI, HF, or pneumonia?
Effect estimate: Rate difference 0.87%
p-value: p=<0.001
Within-hospital disparities in 30-day readmission for dually eligible Medicare/Medicaid patients are only modestly explained by community-level factors, highlighting the need for hospital-level quality improvement to advance equity.
Silvestri et al. (2022) conducted a cohort in Acute myocardial infarction, heart failure, or pneumonia (n=2,588,121). Dual eligibility for Medicare and Medicaid vs. Non-dual eligible Medicare patients was evaluated on Within-hospital disparities in 30-day readmission (adjusted rate difference) for acute myocardial infarction (Rate difference 0.87%, p=<0.001). Within-hospital disparities in 30-day readmission for dual-eligible patients persisted after accounting for state- and community-level factors, with an adjusted rate difference of 0.87% for acute myocardial infarction, 0.67% for heart failure, and 0.42% for pneumonia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: